This inventor holds 7 USPTO granted patents and 1 published patent application. Top assignees: Boehringer Ingelheim Pharmaceuticals, Inc., Washington University, Boehringer Ingelheim International Gmbh. Active years: 2007-2015.
Company Filing History:
3 out of 277 
3 out of 1,374 
1 out of 1,560 
Years Active: 2007-2015
Title: Innovations by Jianfei Yang
Introduction
Jianfei Yang is a notable inventor based in Sandy Hook, CT (US). He has made significant contributions to the field of immunology, particularly through his innovative research and patents. With a total of 7 patents, Yang has established himself as a key figure in the development of therapeutic methods for modulating lymphocyte activity.
Latest Patents
Yang's latest patents focus on compositions and methods for modulating lymphocyte activity. One of his notable inventions introduces a novel lymphocyte inhibitory receptor termed BTLA, which is expressed on both T and B cells. This invention identifies HVEM as interacting with BTLA. The methods and compositions provided aim to modulate BTLA-mediated signaling and interfere with the interaction of BTLA and HVEM for therapeutic, diagnostic, and research purposes.
Career Highlights
Throughout his career, Jianfei Yang has worked with prestigious institutions, including Washington University and Boehringer Ingelheim Pharmaceuticals, Inc. His work has significantly advanced the understanding of lymphocyte activity and its implications for various therapeutic applications.
Collaborations
Yang has collaborated with esteemed colleagues such as Jun Li and Norihiko Watanabe, contributing to the advancement of research in his field.
Conclusion
Jianfei Yang's innovative work and patents have made a lasting impact on immunology and therapeutic development. His contributions continue to influence research and applications in the modulation of lymphocyte activity.